Varian strikes supply agreements in oncology

Article

HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared

HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared Services (MAGNET) has also renewed a preferred pricing agreement for Varian to supply members with radiotherapy equipment. The contracts cover a range of equipment including Ximatron treatment simulators, linear accelerators, and SmartBeam IMRT (intensity-modulated radiation therapy), a highly precise radiation therapy technology.

HealthTrust is one of the nation's largest healthcare group purchasing organizations with a current membership of more than 600 facilities. Members of MAGNET, one of the oldest, largest, and most experienced shared service/GPOs in the U.S., serve over 775 hospitals and 1100 nursing homes, along with more than 5000 physicians and 1000 allied healthcare organizations in 20 states.

© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.